| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/IAI.74.5.2867-2875.2006 |
| P8608 | Fatcat ID | release_7gjzx4tnczfzng6atxqv66tp4y |
| P932 | PMC publication ID | 1459698 |
| P698 | PubMed publication ID | 16622225 |
| P50 | author | Thor G. Theander | Q54802168 |
| Lars Hviid | Q55174838 | ||
| David Cavanagh | Q60648233 | ||
| Bruno P Mmbando | Q85689358 | ||
| Martha M Lemnge | Q87131272 | ||
| John Lusingu | Q90228924 | ||
| Lasse S Vestergaard | Q114320005 | ||
| Andrew Y Kitua | Q114320945 | ||
| P2093 | author name string | Samwel Gesase | |
| Anja T R Jensen | |||
| Michael B Dalgaard | |||
| Daniel T Minja | |||
| P2860 | cites work | Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions | Q24804747 |
| Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 | ||
| The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes | Q29393314 | ||
| Molecular mechanisms of cytoadherence in malaria. | Q33654265 | ||
| The malaria genome sequencing project: complete sequence of Plasmodium falciparum chromosome 2. | Q33852060 | ||
| Plasmodium falciparum clinical malaria: lessons from longitudinal studies in Senegal | Q33852160 | ||
| Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria | Q33852294 | ||
| Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. | Q33866742 | ||
| Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family | Q33924720 | ||
| var genes, PfEMP1 and the human host | Q34293017 | ||
| Evidence for the involvement of VAR2CSA in pregnancy-associated malaria | Q34364093 | ||
| The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes | Q34482933 | ||
| A LONGITUDINAL SURVEY OF NATURAL MALARIA INFECTION IN A GROUP OF WEST AFRICAN ADULTS | Q35398476 | ||
| Progress in the development of recombinant and synthetic blood-stage malaria vaccines. | Q35541797 | ||
| A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes | Q35813897 | ||
| Variant surface antigens, virulence genes and the pathogenesis of malaria | Q35937477 | ||
| Clinical features and pathogenesis of severe malaria | Q35937503 | ||
| Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes | Q36365076 | ||
| Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes | Q36399515 | ||
| Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia | Q36576319 | ||
| The silent burden of anaemia in Tanzanian children: a community-based study | Q36947932 | ||
| The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia | Q37523653 | ||
| Antibodies to the N-terminal block 2 of plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria | Q37582802 | ||
| The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission | Q39023301 | ||
| Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa | Q39111480 | ||
| Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. | Q39417737 | ||
| A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. | Q40640896 | ||
| Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. | Q40734085 | ||
| Cross-sectional study of specific antibodies to a polymorphic Plasmodium falciparum antigen and of parasite antigen genotypes in school children on the slope of Mount Cameroon | Q43558702 | ||
| Relationship Between Altitude and Intensity of Malaria Transmission in the Usambara Mountains, Tanzania | Q43949141 | ||
| Parasite-infected-cell-agglutination and indirect immunofluorescence assays for detection of human serum antibodies bound to antigens on Plasmodium falciparum-infected erythrocytes | Q44521200 | ||
| Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta | Q45249046 | ||
| Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. | Q46334562 | ||
| Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age. | Q46809348 | ||
| Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria | Q47232540 | ||
| A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. | Q47832886 | ||
| Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence | Q47886579 | ||
| Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum | Q47888568 | ||
| Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity | Q47901577 | ||
| Gamma-globulin and acquired immunity to human malaria | Q47957467 | ||
| Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1. | Q48036521 | ||
| Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry | Q77356524 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| Plasmodium falciparum | Q311383 | ||
| membrane protein | Q423042 | ||
| P304 | page(s) | 2867-2875 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Levels of plasma immunoglobulin G with specificity against the cysteine-rich interdomain regions of a semiconserved Plasmodium falciparum erythrocyte membrane protein 1, VAR4, predict protection against malarial anemia and febrile episodes | |
| P478 | volume | 74 |
| Q34147732 | A plasma survey using 38 PfEMP1 domains reveals frequent recognition of the Plasmodium falciparum antigen VAR2CSA among young Tanzanian children |
| Q34060866 | A progressive declining in the burden of malaria in north-eastern Tanzania |
| Q35133809 | Accuracy of malaria rapid diagnostic tests in community studies and their impact on treatment of malaria in an area with declining malaria burden in north-eastern Tanzania |
| Q41813370 | Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1. |
| Q36689554 | Analysis of antibody induction upon immunization with distinct NTS-DBL1α-domains of PfEMP1 from rosetting Plasmodium falciparum parasites |
| Q34103586 | Antibodies against PfEMP1, RIFIN, MSP3 and GLURP are acquired during controlled Plasmodium falciparum malaria infections in naïve volunteers |
| Q56358597 | Antibodies to Intercellular Adhesion Molecule 1-Binding Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLβ Are Biomarkers of Protective Immunity to Malaria in a Cohort of Young Children from Papua New Guinea |
| Q24672872 | Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family |
| Q90341629 | Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it |
| Q37289589 | Epidemiology of malaria in an area prepared for clinical trials in Korogwe, north-eastern Tanzania |
| Q36124623 | Evidence for in vitro and in vivo expression of the conserved VAR3 (type 3) plasmodium falciparum erythrocyte membrane protein 1. |
| Q36336828 | Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania |
| Q34290645 | Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children |
| Q35833840 | IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria |
| Q35783951 | Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria |
| Q34367020 | Insect cells are superior to Escherichia coli in producing malaria proteins inducing IgG targeting PfEMP1 on infected erythrocytes |
| Q35220304 | Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family |
| Q50095537 | Natural and vaccine-induced acquisition of cross-reactive IgG inhibiting ICAM-1-specific binding of a PfEMP1 subtype associated specifically with cerebral malaria |
| Q30883674 | Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern Tanzania |
| Q33700519 | Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes--divide and conquer |
| Q35576130 | Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy |
| Q40043244 | Relationships between sickle cell trait, malaria, and educational outcomes in Tanzania |
| Q36284299 | Reliability of rapid diagnostic tests in diagnosing pregnancy-associated malaria in north-eastern Tanzania. |
| Q37289585 | Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in tanzanian children aged 12-24 months |
| Q36888526 | Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria |
| Q52568248 | Signatures of competition and strain structure within the major blood-stage antigen of Plasmodium falciparum in a local community in Ghana |
| Q35068274 | Spatial variation and socio-economic determinants of Plasmodium falciparum infection in northeastern Tanzania |
| Q34452432 | Structural conservation despite huge sequence diversity allows EPCR binding by the PfEMP1 family implicated in severe childhood malaria |
| Q27313623 | Surface co-expression of two different PfEMP1 antigens on single plasmodium falciparum-infected erythrocytes facilitates binding to ICAM1 and PECAM1 |
| Q34221833 | The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children |
| Q39133249 | The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies |
| Q33846617 | The kinetics of antibody binding to Plasmodium falciparum VAR2CSA PfEMP1 antigen and modelling of PfEMP1 antigen packing on the membrane knobs |
| Q36453649 | Using community-owned resource persons to provide early diagnosis and treatment and estimate malaria burden at community level in north-eastern Tanzania |
Search more.